[Alterations in the level of N5 methyl tetrahydrofolate observed in the CSF of epileptics treated with anticonvulsants].
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D002220:Carbamazepine / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010634:Phenobarbital / Q000494:pharmacology / Q000627:therapeutic use; D010672:Phenytoin / Q000494:pharmacology / Q000627:therapeutic use; D013763:Tetrahydrofolates / Q000097:blood / Q000134:cerebrospinal fluid*; D013997:Time Factors
D000927:Anticonvulsants; D013763:Tetrahydrofolates; D002220:Carbamazepine; D010672:Phenytoin; D010634:Phenobarbital
Etude des modifications du taux de N5 méthyl tétrahydrofolate observées dans le L.C.R. des épileptiques traités par les anticonvultivants